About the Authors
- Kassem Bourgi
-
* E-mail: kbourgi@aol.com
Affiliation Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, United States of America
- Indira Brar
-
Affiliation Division of Infectious Diseases, Henry Ford Hospital, Detroit, MI, United States of America
- Kimberly Baker-Genaw
-
Affiliation Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, United States of America
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Kassem Bourgi and Dr. Kimberly Baker-Genaw have no conflicts of interest. Dr. Indira Brar has served as a speaker, advisory board member and received research funding from Gilead Sciences. Dr. Brar has served as a speaker and received research funding from Janssen Pharmaceutica. She has also received research funding from ViiV Healthcare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: KB IB KBG. Data curation: KB. Formal analysis: KB. Investigation: KB. Methodology: KB IB KBG. Supervision: IB KBG. Validation: KB. Visualization: KB IB KBG. Writing - original draft: KB. Writing - review & editing: KB IB KBG.